Role of different cytokines and seizure susceptibility: A new dimension towards epilepsy research

Indian Journal of Experimental Biology

Volumn 47, Issue 8, 2008, Pages 625-634

  Rao, R S ^a   Prakash, A ^a   Medhi, B ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antiepileptic drugs; Cytokines; Epilepsy; Inflammation

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANIMAL; EPILEPSY; HUMAN; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEIZURE;

ANIMALS; BIOMEDICAL RESEARCH; CYTOKINES; EPILEPSY; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; SEIZURES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349327982     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Porter R J, Therapy of epilepsy, Curr Opin Neurol Neurosurg, 1 (1988) 206.
2. Lowenstein D H, Seizures and epilepsy, in Harrison's principles of internal medicine, Vol. 1, edited by E Braunwald, A S Fauci, D L Kasper, SL Hauser, D L Longo and J L Jameson, (McGraw-Hill Medical Publishing Division, New York) 2001, 2354.
3. Kidd B L & Urban L A, Mechanism of inflammatory pain, Br J Anaesth, 87 (2001) 3.
4. Vezzani A, Inflammation and epilepsy, Epilepsy Curr, 5 (2005) 1.
5. (Pubitemid 44414994) Bonifati D M & Kishore U, Role of complement in neurodegeneration and neuroinflammation, Mol Immunol, 44 (2007) 999.
6. (Pubitemid 38859542) Lahteinen S, Pitkanen A, Knuuttila J, Toronen P & Castren E, Brain-derived neurotrophic factor signaling modifies hippocampal gene expression during epileptogenesis in transgenic mice, Eur J Neurosci, 19 (2004) 3245.
7. Acute and chronic inflammation, in: Robbins and Cotran pathologic basis of disease. Kumar V, Abbas A K, & Fausto N (Elsevier Saunders: Philadelphia, Pennsylvania), 2004, 47.
8. De Sarro G, Rotiroti D, Audino M G, Gratteri S & Nisticó G, Effects of interleukin-2 on various models of experimental epilepsy in DBA/2 mice, Neuroimmunomodulation, 1 (1994) 361.
9. McNamara J O, Pharmacotherapy of epilepsies. in: Goodman & Gilman's The pharmacological basis of therapeutics. edited by L L Brunton, J S Lazo, K L Parker, (McGraw-Hill medical Publishing Division, Newyork), 2006, 501.
10. Rothwell N J. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci, 12 (1991) 430.
11. Masotto C, Caspani G, De Simoni MG, Mengozzi M, Scatturin M, Sironi M, Carenzi A, Ghezzi P, Evidence for a different sensitivity to various central effects of interleukin-1 beta in mice, Brain Res Bull, 28 (1992) 161.
12. Fann M J & Patterson P H, A novel approach to screen for cytokine effects on neuronal gene expression, J Neurochem, 61 (1993) 1349.
13. Dunn A J, Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone, Life Sci, 43 (1988) 429.
14. Merrill J E, Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological, Dev Neurosci, 14 (1992) 1.
15. Benveniste E N, Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action, Am J Physiol, 263 (1992) C1.
16. Kresyun V I, Kobolev E V, Smirnov I V, Godovan V V & Godlevsky L S, Effects interferon-2alpha on seizures in corasol-induced kindling, Bull Exp Biol Med, 144 (2007) 8.
17. Bartfai T & Schultzberg M, Cytokines in neuronal cell types, Neurochem Int, 22 (1993) 435.
18. Hopkins S J & Rothwell N J, Cytokines and the nervous system. I: Expression and recognition, Trends Neurosci, 18 (1995) 83.
19. (Pubitemid 44921957) Vezzani A & Granata T, Brain inflammation in epilepsy: Experimental and clinical evidence, Epilepsia, 46 (2005) 1724.
20. (Pubitemid 28389722) Munoz-Fernandez M A & Fresno M, The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system, Prog Neurobiol, 56 (1998) 307.
21. (Pubitemid 27458802) Pan W, Zadina J E, Harlan R E, Weber J T, Banks W A & Kastin A J, Tumor necrosis factor-alpha: A neuromodulator in the CNS, Neurosci Biobehav Rev, 21 (1997) 603.
22. Vezzani A, Moneta D, Richichi C, Perego C, & De Simoni M. G, Functional role of proinflammatory and antiinflammatory cytokines in seizures, Adv Exp Med Biol, 548 (2004) 123.
23. Shandra A A, Godlevsky L S, Vastyanov R S, Oleinik A A, Konovalenko V L, Rapoport E N & Korobka N N, The role of TNF-alpha in amygdala kindled rats, Neurosci Res, 42 (2002) 147.
24. (Pubitemid 30780930) Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni M G, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K & Bartfai T, Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice, Proc Natl Acad Sci U S A, 97 (2000) 11534.
25. (Pubitemid 40962132) Ravizza T, Rizzi M, Perego C, Richichi C, Velísková J, Moshé S L, De Simoni M G & Vezzani A, Inflammatory response and glia activation in developing rat hippocampus after status epilepticus, Epilepsia, 46 (2005) 113.
26. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Velískǒvá J, Moshé S L, De Simoni M G & Vezzani A, Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development, Neurobiol Dis, 14 (2003) 494.
27. (Pubitemid 43031496) Ravizza T & Vezzani A, Status epilepticus induces timedependent neuronal and astrocytic expression of interleukin- 1 receptor type I in the rat limbic system, Neuroscience, 137 (2006) 301.
28. (Pubitemid 30497055) De Simoni M G, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S & Vezzani A, Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus, Eur J Neurosci, 12 (2000) 2623.
29. (Pubitemid 41500836) Cunningham C, Wilcockson D C, Campion S, Lunnon K & Perry VH, Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration, J Neurosci, 25 (2005) 9275.
30. Gayle D A, Ling Z, Tong C, Landers T, Lipton J W & Carvey P M, Lipopolysaccharide (LPS) -induced dopamine cell loss in culture: Roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide, Brain Res Dev Brain Res, 133 (2002) 27.
31. Zheng Z & Yenari M A, Post-ischemic inflammation: Molecular mechanisms and therapeutic implications, Neurol Res, 26 (2004) 884.
32. Hong Y B, Kim E Y & Jung S C, Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse, J Korean Med Sci, 21 (2006) 733.
33. (Pubitemid 29270140) Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F & De Simoni M G, Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures, J Neurosci, 19 (1999) 5054.
34. (Pubitemid 30198634) Eriksson C, Tehranian R, Iverfeldt K, Winblad B & Schultzberg M, Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration, J Neurosci Res, 60 (2000) 266.
35. Heida J G & Pittman Q J, Causal links between brain cytokines and experimental febrile convulsions in the rat, Epilepsia, 46 (2005) 1906.
36. (Pubitemid 44416213) Ravizza T, Boer K, Redeker S, et al, The IL-1beta system in epilepsy-associated malformations of cortical development, Neurobiol Dis, 24 (2006) 128.
37. Ravizza T, Boer K, Redeker S, Spliet W G, van Rijen P C, Troost D, Vezzani A & Aronica E, Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases, J Neurosci, 23 (2003) 8692.
38. Cytokines. in: Kelleys textbook of rheumatology, Vol. 1. edited by L B Mc Innes. (Elsevier Saunders :Philadelphia, Pennsylvania) 2005, 379.
39. (Pubitemid 43882945) Amaral M E, Barbuio R, Milanski M, Romanatto T, Barbosa H C, Nadruz W, Bertolo M B, Boschero A C, Saad M J, Franchini K G & Velloso L A, Tumor necrosis factor-alpha activates signal transduction in hypothalamus and modulates the expression of pro-inflammatory proteins and orexigenic/anorexigenic neurotransmitters, J Neurochem, 98 (2006) 203.
40. (Pubitemid 41023141) Bernardino L, Xapelli S, Silva A P, Jakobsen B, Poulsen F R, Oliveira C R, Vezzani A, Malva J O & Zimmer J, Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures, J Neurosci, 25 (2005) 6734.
41. (Pubitemid 36184697) Lehtimaki K A, Peltola J, Koskikallio E, Keranen T & Honkaniemi J, Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures, Brain Res Mol Brain Res, 110 (2003) 253.
42. (Pubitemid 32155877) Penkowa M, Molinero A, Carrasco, J & Hidalgo, J, Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures, Neuroscience, 102 (2001) 805.
43. (Pubitemid 44622225) Qian L, Hong J S & Flood P M, Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10, J Neural Transm Suppl, 70 (2006) 367.
44. Croll S D, Goodman J H & Scharfman H E, Vascular endothelial growth factor (VEGF) in seizures: A doubleedged sword, Adv Exp Med Biol, 548 (2004) 57.
45. (Pubitemid 40962122) Zucchini S, Barbieri M & Simonato M, Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the fibroblast growth factor-2 system, Epilepsia, 46 (2005) 52.
46. (Pubitemid 38993907) Tongiorgi E, Armellin M, Giulianini P G, Bregola G, Zucchini S, Paradiso B, Steward O, Cattaneo A & Simonato M, Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis, J Neurosci, 24 (2004) 6842.
47. Yoo Y M, Lee C J, Lee U & Kim Y J, Neuroprotection of adenoviral-vector-mediated GDNF expression against kainicacid-induced excitotoxicity in the rat hippocampus, Exp Neurol, 200 (2006) 407.
48. (Pubitemid 29108529) Yuhas Y, Shulman L, Weizman A, Kaminsky E, Vanichkin A & Ashkenazi S, Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae, Infect Immun, 67 (1999) 1455.
49. (Pubitemid 24289604) Perdomo O J, Cavaillon J M, Huerre M, Ohayon H, Gounon P & Sansonetti P J, Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis, J Exp Med, 180 (1994) 1307.
50. Watkins L R, Maier S F & Goehler L E, Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states, Pain, 63 (1995) 289.
51. Gutierrez E G, Banks W A & Kastin A J, Murine tumor necrosis factor alpha is transported from blood to brain in the mouse, J Neuroimmunol, 47 (1993) 169.
52. (Pubitemid 26039774) Chao C C, Hu S, Ehrlich L & Peterson P K, Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors, Brain Behav Immun, 9 (1995) 355.
53. Moncada S & Higgs A, The L-arginine-nitric oxide pathway, N Engl J Med, 329 (1993) 2002.
54. (Pubitemid 27011321) Johansson B, Georgiev V, Kuosmanen T & Fredholm B B, Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazolinduced seizures in mice. Relationship to c-fos expression and receptor binding, Eur J Neurosci, 8 (1996) 2447.
55. Kovács Z, Kékesi K A, Szilágyi N, Abrahám I, Székács D, Király N, Papp E, Császár I, Szego E, Barabás K, Péterfy H, Erdei A, Bártfai T & Juhász G, Facilitation of spike-wave discharge activity by lipopolysaccharides in wistar albino Glaxo/Rijswijk rats, Neuroscience, 140 (2006) 731.
56. (Pubitemid 14006351) Foote F & Gale K, Proconvulsant effect of morphine on seizures induced by pentylenetetrazol in the rat, Eur J Pharmacol, 105 (1984) 179.
57. Lauretti G R, Ahmad I & Pleuvry B J, The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole, Neuropharmacology, 33 (1994) 155.
58. (Pubitemid 34127715) Homayoun H, Khavandgar S, Namiranian K, Gaskari S A & Dehpour A R, The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice, Epilepsy Res, 48 (2002) 33.
59. Fiocchi C, The immune system in inflammatory bowel disease, Acta Gastroenterol Belg, 60 (1997) 156.
60. MacDermott R P, Sanderson I R & Reinecker H C, The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease, Inflamm Bowel Dis, 4 (1998) 54.
61. Salzet M, Neuroimmunology of opioids from invertebrates to human, Neuro Endocrinol Lett, 22 (2001) 467.
62. Stefano G B, Scharrer B, Smith E M, Hughes T K Jr, Magazine H I, Bilfinger T V, Hartman A R, Fricchione G L, Liu Y & Makman MH, Opioid and opiate immunoregulatory processes, Crit Rev Immunol, 16 (1996) 109.
63. Binder D K, Croll S D, Gall C M & Scharfman H E, BDNF and epilepsy: too much of a good thing? Trends Neurosci, 24 (2001) 318.
64. Jankowsky J L & Patterson P H, The role of cytokines and growth factors in seizures and their sequelae, Prog Neurobiol, 63 (2001) 125.
65. (Pubitemid 24321453) Redman B G, Abubakr Y, Chou T, Esper P & Flaherty L E, Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma, J Immunother Emphasis Tumor Immunol, 16 (1994) 211.
66. Pluzanska A, Recombinant human tumor necrosis factor alpha (TNF) : Preclinical studies and results of early clinical trials, Acta Haematol Pol, 25 (1994) 148.
67. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G & Kollias G, Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha, Proc Natl Acad Sci U S A, 92 (1995) 11294.
68. (Pubitemid 37455865) Foley J E, Rand C & Leutenegger C, Inflammation and changes in cytokine levels in neurological feline infectious peritonitis, J Feline Med Surg, 5 (2003) 313.
69. Loscher C E, Donnelly S, Lynch M A & Mills K H, Induction of inflammatory cytokines in the brain following respiratory infection with Bordetella pertussis, J Neuroimmunol, 102 (2000) 172.
70. Rao R S, Medhi B, Saikia U N, Arora S K, Toor J S, Khanduja K L & Pandhi P, Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat, Eur Neuropsychopharmacol, 10 (2008) 760.
71. (Pubitemid 30107811) Ichiyama T, Okada K, Lipton J M, Matsubara T, Hayashi T & Furukawa S, Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB, Brain Res, 857 (2000) 246.
72. (Pubitemid 34143441) Verrotti A, Basciani F, Trotta D, Greco R, Morgese G & Chiarelli F, Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1, Clin Exp Med, 1 (2001) 133.
73. (Pubitemid 38887691) Hulkkonen J, Koskikallio E, Rainesalo S, Keränen T, Hurme M & Peltola J, The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients, Epilepsy Res, 59 (2004) 199.
74. (Pubitemid 46587627) Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I & Janigro D, Seizure-promoting effect of blood-brain barrier disruption, Epilepsia, 48 (2007) 732.
75. Gallowitsch-Puerta M & Pavlov V A, Neuro-immune interactions via the cholinergic anti-inflammatory pathway, Life Sci, 80 (2007) 2325.
76. (Pubitemid 40872738) Ganor Y, Freilinger M, Dulac O & Levite M, Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines, Autoimmunity, 38 (2005) 139.
77. (Pubitemid 37279301) Sariola H & Saarma M, Novel functions and signalling pathways for GDNF, J Cell Sci, 116 (2003) 3855.
78. Bauer S & Patterson P H, Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain, J Neurosci, 26 (2006) 12089.
79. (Pubitemid 37280954) Numakawa T, Nakayama H, Suzuki S, Kubo T, Nara F, Numakawa Y, Yokomaku D, Araki T, Ishimoto T, Ogura A & Taguchi T, Nerve growth factor-induced release is via p75 receptor, ceramide, and Ca (2+) from ryanodine receptor in developing cerebellar neurons, J Biol Chem, 278 (2003) 41259.
80. Ness J K, Mitchell N E & Wood T L, IGF-I and NT-3 signaling pathways in developing oligodendrocytes: Differential regulation and activation of receptors and the downstream effector Akt, Dev Neurosci, 24 (2002) 437.